# Critic Response

## Review scope

- Single critic stage.
- Reviewed only the evidence-verifier response and only its four `Verified` findings: V1, V3, V4, and V5.
- Assessed document grounding, logical validity, allowed taxonomy, duplication, and claim strength.
- Did not reopen source documents, search for new issues, use external information, or conduct another verification stage.
- Final scientific issues retained: 4 of a maximum of 10.

## Disposition summary

| Verifier ID | Critic disposition | Severity | Final category |
|---|---|---|---|
| V1 / TAC-01 | Retained | Minor | Presentation inconsistency |
| V3 / FFC-2 | Retained | Minor | Statistical reporting inconsistency |
| V4 / FFC-3 | Retained | Minor | Presentation inconsistency |
| V5 / SCC-01 | Retained | Minor | Statistical reporting inconsistency |

The four findings are not duplicates. V1 concerns Table 2's participant-count framing; V3 concerns the population stated for one prespecified subgroup; V4 concerns missing denominators and missing-classification disclosure in Figure 2; and V5 concerns the narrative interpretation of a secondary outcome. None establishes an error in the primary treatment-effect result, so none is classified as Major.

## Retained final scientific issues

### 1. Surgeon-level categories exceed the participant denominators without a multiple-response note

**Severity:** Minor  
**Category:** Presentation inconsistency  
**Verifier source:** V1 / TAC-01

- **Location:** `jama_atherton_2025_oi_240145_1741627844.85412.pdf`, PDF p. 7 (printed JAMA p. 859), Table 2, "Level of operating surgeon," "Level of surgeon closing fascia," and "Level of surgeon closing skin."
- **Source values/statements:** The table header is "No. of participants (%)" and gives iNPWT `n = 411` and surgeon's preference `n = 410`.
  - Operating surgeon: `319, 123, 4` and `318, 110, 1`.
  - Surgeon closing fascia: `201, 218, 26` and `193, 225, 15`.
  - Surgeon closing skin: `115, 214, 96` and `102, 241, 73`.
  - Footnote `f` defines international seniority equivalents but does not state that categories are non-mutually exclusive or that multiple surgeons may be counted for one participant.
- **Calculation/logical basis:**
  - Operating surgeon: `319 + 123 + 4 = 446`, exceeding 411 by 35; `318 + 110 + 1 = 429`, exceeding 410 by 19.
  - Closing fascia: `201 + 218 + 26 = 445`, exceeding 411 by 34; `193 + 225 + 15 = 433`, exceeding 410 by 23.
  - Closing skin: `115 + 214 + 96 = 425`, exceeding 411 by 14; `102 + 241 + 73 = 416`, exceeding 410 by 6.
  - Percentages also sum above 100% in every block. The document may have permitted multiple surgeons or levels per participant, but the participant-count heading and footnotes do not disclose that recording rule. The retained finding is limited to ambiguous presentation; it does not claim that the underlying counts are wrong.
- **Human verification instruction:** On Table 2, add each three-level surgeon block and read footnote `f`. Confirm from the source tabulation whether more than one surgeon or level could be recorded per operation. If so, add an explicit non-mutually-exclusive/multiple-response note; otherwise, recheck the counts.

### 2. The Methods omits the UK-only restriction for the pandemic subgroup

**Severity:** Minor  
**Category:** Statistical reporting inconsistency  
**Verifier source:** V3 / FFC-2

- **Locations:**
  - `jama_atherton_2025_oi_240145_1741627844.85412.pdf`, PDF p. 4 (printed JAMA p. 856), Statistical Analysis.
  - Same PDF, p. 9 (printed p. 861), Figure 2, "SARS-CoV-2 pandemic" rows and footnote `a`.
  - `joi240145supp1_prod_1741627844.87412.pdf`, PDF p. 28, SAP section 9.9.
- **Source values/statements:**
  - Main Methods describes a subgroup based on "the date the global pandemic was declared (patients randomized before or after March 11, 2020)" without stating a country restriction.
  - Figure 2 footnote `a` states "UK-based patients only."
  - The pandemic rows report events `60` and `19` for iNPWT and `55` and `18` for surgeon's preference.
  - Figure 2's UK country row reports `79` and `73` events. The primary totals are `112` and `108`.
  - SAP section 9.9 plans "Date of COVID-19 as per World Health Organization (For UK patients only)."
- **Calculation/logical basis:** `60 + 19 = 79` and `55 + 18 = 73`, exactly matching the UK-row event totals rather than the all-country primary totals of 112 and 108. The figure and SAP therefore identify a UK-only analysis, whereas the Methods subgroup description omits that population restriction. The retained claim is limited to the mismatch in the stated analysis population.
- **Human verification instruction:** Read the complete pandemic-subgroup sentence on main PDF p. 4, then Figure 2 footnote `a` and the two pandemic event rows on p. 9. Add the row counts and compare them with the UK row. Reconcile the Methods wording with the planned and displayed UK-only analysis.

### 3. Figure 2 omits subgroup-category denominators and does not disclose missing subgroup classifications

**Severity:** Minor  
**Category:** Presentation inconsistency  
**Verifier source:** V4 / FFC-3

- **Location:** `jama_atherton_2025_oi_240145_1741627844.85412.pdf`, PDF p. 9 (printed JAMA p. 861), Figure 2.
- **Source values/statements:** Figure 2 labels its numeric columns "No. of patients with SSI within 30 d of procedure" and gives only the overall group sizes `n = 394` and primary event totals `112` and `108`. It provides event numerators and adjusted RRs for each category, but not category-specific denominators, missing/unknown categories, or a complete-case subgroup footnote. Its only footnote is the UK-only pandemic note.
- **Calculation/logical basis:**
  - BMI events: iNPWT `5 + 33 + 30 + 41 = 109`, leaving `112 - 109 = 3`; control `4 + 37 + 30 + 32 = 103`, leaving `108 - 103 = 5`.
  - Incision-length events: iNPWT `21 + 90 = 111`, leaving 1; control `22 + 81 = 103`, leaving 5.
  - Assessment-method events: iNPWT `77 + 15 + 9 = 101`, leaving 11; control `78 + 16 + 13 = 107`, leaving 1.
  - These shortfalls show that some primary-outcome events are absent from the displayed category rows. Missing subgroup data may explain the shortfalls and would not by itself invalidate the adjusted RRs, but the figure does not give category denominators or quantify missing subgroup classifications. The retained finding is limited to incomplete or ambiguous presentation; it does not claim that the subgroup estimates are numerically wrong.
- **Human verification instruction:** For BMI, incision length, and assessment method, total the displayed event numerators against 112 and 108, then inspect the caption and footnote for missing-data disclosure. Request category denominators and missing/unknown counts, or add an explicit complete-case subgroup-analysis note.

### 4. The unqualified "no differences in quality of life" narrative conflicts with the displayed day-7 EuroQol contrast

**Severity:** Minor  
**Category:** Statistical reporting inconsistency  
**Verifier source:** V5 / SCC-01

- **Locations:**
  - `jama_atherton_2025_oi_240145_1741627844.85412.pdf`, PDF p. 1 (printed JAMA p. 853), Abstract Results.
  - Same PDF, p. 6 (printed p. 858), Secondary Outcomes.
  - `joi240145supp3_prod_1741627844.89412.pdf`, PDF p. 4, Supplementary eTable 3, EQ5D-5L EuroQol score, Day 7.
- **Source values/statements:**
  - The Abstract says that 6 of 7 secondary outcomes "showed no significant difference," explicitly including quality of life.
  - Main Results states, "There were no differences in quality of life between the 2 groups (eTables 2-4 in Supplement 3)."
  - Supplementary eTable 3, day 7: `N = 292` vs `283`; means `0.44 (SD 0.32)` vs `0.49 (SD 0.30)`; adjusted mean difference `-0.057 (95% CI, -0.104 to -0.010)`, `P = .02`.
  - The eTable footnote states that surgeon's preference is the reference and values greater than 0 favor iNPWT; the negative estimate therefore favors surgeon's preference.
  - Treatment-by-time interaction: `P = .10`.
- **Calculation/logical basis:** The day-7 confidence interval is wholly below the null value 0 and the displayed time-specific P value is below .05, which does not match the unqualified narrative that quality of life showed no difference. The nonsignificant interaction may be the intended global inferential basis, and multiplicity may affect interpretation, but neither qualification appears in the cited narrative. The retained finding is therefore a reporting mismatch only; it does not assert a significant overall longitudinal treatment effect.
- **Human verification instruction:** Compare the two unqualified main-article quality-of-life statements with eTable 3's day-7 estimate, confidence interval, P value, and interaction P value. Clarify whether the conclusion rests on the global interaction or the time-specific contrasts, and qualify the narrative accordingly.

## Rejected and uncertain candidates for report

These items must remain outside the final scientific issue list.

### Rejected

- **V2 / merged FFC-1 and SCC-02:** Rejected by the verifier. The allegation that Figure 2 added an unplanned incision-length subgroup and omitted a planned recruiting-center subgroup is not supported. Supplement 1, PDF p. 28, SAP section 9.9 prespecifies "Size of wound" with the same `<15 cm` and `>=15 cm` cutoff used by Figure 2's "Length of incision" subgroup, and recruiting center is absent from the SAP's planned subgroup list.

### Uncertain

- **U1 - Wound-related readmission adjusted risk difference:** Main PDF p. 8 (printed p. 860), Table 3. The crude contrast from `11/399 (3%)` versus `11/398 (3%)` is approximately zero, whereas the adjusted RD is `0.010 (95% CI, -0.014 to 0.034)` and adjusted RR is `1.02 (95% CI, 0.45 to 2.31)`, `P = .96`. The Methods states that the adjusted RD and RR came from separate mixed-effects binomial models, and the supplied documents do not provide the fitted model outputs needed to determine whether `0.010` is erroneous. Human check: inspect the original model output or typesetting source.
- **U2 - Figure 1 total deaths versus Table 3 30-day mortality:** Main PDF p. 3 (printed p. 855), Figure 1 footnote `b`; p. 6 (printed p. 858), Safety Outcomes; and p. 8 (printed p. 860), Table 3. Figure 1 reports 25 deaths (`10` and `15`), while the 30-day mortality result reports 24 (`10/411` and `14/410`). The documents cited by the verifier do not establish that all 25 Figure 1 deaths occurred within 30 days. Human check: confirm the time window for the 15 control-group deaths and reconcile only if all occurred within 30 days; otherwise make the time distinction explicit.

## Critic conclusion

Retain V1, V3, V4, and V5 as four Minor final scientific issues with the narrowed claim language above. Carry V2 as Rejected and U1-U2 as Uncertain in the report's separate disposition section. No additional issues were sought or added.
